Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Adastra Holdings Ltd C.XTRX

Alternate Symbol(s):  XTXXF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis Cannabis
Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. The Company extracts and processes cannabis for sale to the recreational and medical markets in Canada using its large-scale extraction facility (the Facility) to produce a variety of products, including vape pens, wax, resin, infused pre-rolls, diamonds and shatter. It serves medical markets and engages in therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are well established with a solid distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Its subsidiaries include Adastra Labs Holdings (2019) Ltd., Adastra Labs Inc., 1178562 B.C. Ltd., Adastra Brands Inc., and others.


CSE:XTRX - Post by User

Adastra Holdings Ltd > Receives Flower Sales License from Health Canada
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3018)
•••
Post by Betteryear2on Dec 20, 2021 1:01pm
6236 Views
Post# 34247361

Receives Flower Sales License from Health Canada

Receives Flower Sales License from Health Canada LANGLEY, BC, Dec. 20, 2021 /CNW/ - Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") today announced that the Company's wholly-owned subsidiary Adastra Labs Inc. ("Adastra Labs") has received its flower sales license amendment from Health Canada effective December 17, 2021 (the "Flower Sales License"). The Flower Sales License will allow Adastra Labs to sell dried cannabis flower products provincially and territorially in Canada through authorized distributors and retailers.


https://www.newswire.ca/en/releases/archive/December2021/20/c8081.html
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities